Article
Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study
2020-09-09
Abstract excerpt
<h4>Background</h4> Hydroxychloroquine has been shown to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro, but early clinical studies found no benefit treating patients with coronavirus disease 2019 (COVID-19). We set out to evaluate the effectiveness of hydroxychloroquine for prevention, as opposed to treatment, of COVID-19 mortality. <h4>Methods</h4> We pre-specified and conducted an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8b53655-aa2a-5120-8530-ef9d522bbdf4
- DOI
- 10.1101/2020.09.04.20187781
